• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA TPE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA TPE SET Back to Search Results
Catalog Number 70500
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Nausea (1970); No Information (3190)
Event Date 06/03/2017
Event Type  Injury  
Manufacturer Narrative
Lot number, expiry and manufacture date are not available at this time.Investigation: per the customer, hypotension occured in spite of ordering 110% fluid balance,100% albumin, up to 20 ml of iv cacl2 and inlet speed not exceeding 80.According to therapeutic apheresis: a physician's handbook, adverse events occur during therapeutic procedures with a frequency of 4.8%.Transient hypocalcemia associated with apheresis is usually well tolerated.Symptoms often show as paraesthesia (tingling) but patients may also experience unusual taste, nausea, lightheadedness, shivering, and tremors.Severe hypocalcemia may also cause muscle contractions and can progress to tetany and seizures if hypocalcemia escalates and is not corrected.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that near the end of a therapeutic plasma exchange (tpe) procedure,a patient experienced hypotension and complained of nausea.The procedure was paused and the patient was given a saline bolus via iv, and was re-positioned.The customer declined to provide patient outcome.The cobe spectra tpe set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information.Investigation: during follow-up, the customer stated that per the customer¿s site standard operating procedures, the patient's blood pressure was checked every 15 minutes.They typically use 75% (5%albumin) and 25% normal saline (ns) replacement and alternate between the two in roughly even volumes starting with ns, ending with albumin.The customer also stated that they do not believe that there is a correlation between the symptoms the patient experienced and the replacement fluid.The customer's investigation did not yield any unusual results and there have been no additional incidents.According to therapeutic apheresis: a physician's handbook, adverse events occur during therapeutic procedures with a frequency of 4.8%.Transient hypotension and nausea associated with apheresis are usually well tolerated.The following progression is often observed: pallor and sweating begin, with the skin turning cold, the pulse slows strikingly, the blood pressure decreases and nausea.The run data file (rdf) was analyzed for this event.Rdf analysis confirmed that there was nothing unusual noted in the rdf about the procedural run.The rdf analysis confirmed that spectra optia system operated as intended.The customer did not provide the lot number pertaining to this event, therefore a device history record (dhr) search could not be conducted for this specific incident.All lots must meet acceptance criteria before release.Root cause: a definitive root cause for the patient's reaction could not be determined.Possible causes for the alleged reactions include but are not limited to the patient's physiology, the patient's disease state, and/or patient sensitivity to the procedure.
 
Manufacturer Narrative
This report is being filed to provide corrected information.Corrected information: no rdf analysis was performed for this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBE SPECTRA BLOOD COLLECTION
Type of Device
COBE SPECTRA TPE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w. collins ave
lakewood, CO 
3032392246
MDR Report Key6689729
MDR Text Key79239093
Report Number1722028-2017-00286
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK020041
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 07/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number70500
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/16/2017
Initial Date FDA Received07/06/2017
Supplement Dates Manufacturer Received07/12/2017
07/31/2017
Supplement Dates FDA Received07/28/2017
08/01/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
Patient Weight98
-
-